In recent years, from top-level design to specific measures, the state has issued a number of policies to encourage the development of traditional Chinese medicine, especially in the past two years, including medical insurance payment, optimization of review and approval rules, encouraging traditional Chinese medicine innovation and talent development and other traditional Chinese medicine policies have been intensively introduced, which fully shows that China attaches importance to and supports
the inheritance, innovation and development of traditional Chinese medicine.
At present, under the favorable influence of the obvious improvement of the efficiency of traditional Chinese medicine review, the overseas expansion of traditional Chinese medicine in China is also accelerating
.
It is understood that up to now, China has built 31 national traditional Chinese medicine service export bases, and the total export trade of traditional Chinese medicine products during the "Thirteenth Five-Year Plan" period has also reached 28.
19 billion US dollars; the State Administration of Traditional Chinese Medicine has supported domestic traditional Chinese medicine institutions to build 30 high-quality overseas centers of traditional Chinese medicine in the "Belt and Road" countries, and 56 international cooperation bases of traditional Chinese medicine in China, providing high-quality traditional Chinese medicine services
for the people of the "Belt and Road" countries.
In addition, China and the International Organization for Standardization have also formulated 64 international standards
for traditional Chinese medicine.
It is worth noting that in the context of the country's vigorous promotion of the development of traditional Chinese medicine, all parts of the country are also stepping up the formulation of the future development blueprint of the traditional Chinese medicine industry, among which the overseas development of traditional Chinese medicine has obviously become a key task in many places, and has begun to gradually achieve results
.
Reports show that since the beginning of this year, promoted by favorable factors such as RCEP, the import and export of traditional Chinese medicinal materials in Bozhou City is maintaining rapid growth
.
From January to October, the import and export of Chinese medicinal materials and Chinese proprietary medicines in the city reached 590 million yuan, an increase of 22%.
Among them, exports were 480 million yuan, an increase of 18.
6%, accounting for 76.
2%
of the total export value of traditional Chinese medicinal materials and Chinese proprietary medicines in Anhui Province.
Among the total export value, the total export value of Chinese medicinal materials and Chinese proprietary medicines to RCEP trading partners was 410 million yuan, an increase of 23%, accounting for 85.
4%
of the total export value of Chinese medicinal materials and Chinese proprietary medicines in the city.
In addition to Bozhou, in fact, Guangxi has also performed very well in traditional Chinese medicine going overseas
.
As the frontier window of China's opening up and cooperation with ASEAN, Guangxi has now formed a pattern
of opening up and cooperation in the field of traditional Chinese medicine, mainly ASEAN countries, Hong Kong, Macao and Taiwan, covering more than 40 countries and regions.
At present, Guangxi has gradually become the main channel for the import of ASEAN Chinese medicinal materials, and the variety and quantity of ASEAN Chinese medicinal materials entering customs from the Guangxi port have increased rapidly, and since 2020, the total value of goods has ranked first in China for two consecutive years
.
In addition, in the first quarter of this year, Anqing has also exported Chinese medicinal materials worth 22.
48 million yuan
.
It is worth mentioning that in order to further help enterprises and increase export volume, Anqing Customs is issuing certificates of origin for the export of Chinese medicinal materials to help enterprises enjoy tariff preferences and improve their competitiveness
in the international market.
At the same time, the relevant departments of Anqing are also optimizing business processes, providing appointment inspection services, reporting and inspection, and releasing them with inspection, so as to realize the rapid inspection and release of Chinese medicinal materials, help enterprises open up new markets, and let more high-quality Chinese medicinal materials from Dabieshan go abroad
.
It is worth mentioning that under the background of the continuous acceleration of Chinese medicine products going overseas, many Chinese medicine enterprises have begun to usher in more overseas profits
.
For example, during the 14th Five-Year Plan period, the sales of Angong Niuhuang Pill of Tongrentang Chinese Medicine were very strong
in Southeast Asia.
Zhiyan Consulting has released a research report saying that according to Chinese customs data, the export volume of China's Angong Niuhuang Pills in 2020 was 14,161 kg, a year-on-year increase of 38.
4%; The export value was 29.
383 million US dollars, a year-on-year increase of 17.
6%, of which the region with a large number of exports was Vietnam, followed by Hong Kong and Indonesia
.
In general, under the continuous favorable policies, the industry generally believes that the overall traditional Chinese medicine market will show a steady growth trend in the future, and it will continue to accelerate
in terms of going overseas.
However, it should be noted that there is a dilemma of cultural differences between Chinese and Western medicine in the overseas dissemination of Chinese medicine, and if Chinese medicine wants to accelerate its "going global", industries and enterprises need to continue to build a platform for Chinese medicine scientific research and talent exchange, strengthen talent exchanges, promote universities, Chinese medicine hospitals and famous folk doctors to visit each other to learn and practice, and strengthen the transformation of achievements of Jing and famous doctors; Carry out joint training of talents, establish a joint training mechanism for talents in colleges and universities and R&D institutions, and continue to explore and layout
.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
